#WomenInMedicine Women Community Forum in Marriott Detroit, a great networking opportunity

Join OncLive.com for a Breast Cancer virtual event and Live Q&A on 4/6 at 6:30pm ET. The faculty will focus on the most relevant topics to ultimately improve patient care. #OncLiveIPC #bcsm Register: bit.ly/3sMzH3K

Breast Cancer #OncLiveIPC chaired by Hadeel Assad, MD of Karmanos Cancer Institute on 4/6 at 6:30pm ET. Expert Faculty Jailan Elayoubi, MD; Lawrence Flaherty, MD; and Michael Simon, MD OncLive SOSS Register: bit.ly/3sMzH3K

Defining HER2-low breast cancer is a task for oncologists & pathologists. 60% of breast cancers are HER2 low based on the DESTINY-Breast04 parameters. Sara Tolaney David Rimm Dana-Farber Johns Hopkins University Johns Hopkins Medicine Yale School of Medicine ASCO #ASCO22 #bcsm ow.ly/a5po50KCyXm

 Are you registered for this year’s Breast Cancer Symposium yet? Don’t delay; the deadline is approaching! This year’s symposium will be held at the Somerset Inn on Saturday, March 4, from 7:30 a.m. – 2:30 p.m. See flyer for details.

Informative breast cancer session with Lynn Henry (U-M Rogel Cancer Center), Dr. Dana Zakalik (Beaumont Health), and Hadeel Assad, MD & Dr. Daniel Isaac of Karmanos Cancer Institute here at 2023 Midwest Precision Oncology Symposium. Great speakers and input all around!

Please join me for Karmanos Cancer Institute’s Annual 2024 Breast Cancer Symposium on Feb. Sept. 23 at the Somerset Inn. I will be presenting on New Advances in Breast Cancer Management: Practice Changing Updates. Register here: karmanos.org/breastcancersy…